Virtus KAR Health Sciences Fund
Virtus KAR Health Sciences Fund reported 25 holdings worth US$91.7M as of Jun 30, 2026 (Form N-PORT)
As of Jun 30, 2026 · Filed Aug 28, 2026
Virtus KAR Health Sciences Fund reported 25 holdings worth US$91.7M as of Jun 30, 2026. Largest: Eli Lilly And Company, West Pharmaceutical Services, Inc. and Abbvie Inc. Filed Aug 28, 2026 (Form N-PORT).
- Holdings
- 25
- Value as reported
- US$91.7M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Eli Lilly And Company | 11,348 | US$13.6M | 14.8% |
| West Pharmaceutical Services, Inc. | 15,110 | US$5.42M | 5.9% |
| Abbvie Inc. | 20,131 | US$5.07M | 5.5% |
| Vertex Pharmaceuticals Incorporated | 9,813 | US$4.87M | 5.3% |
| Merck & Company, Inc. | 36,134 | US$4.64M | 5.1% |
| Unitedhealth Group Incorporated | 10,264 | US$4.27M | 4.7% |
| Mckesson Corporation | 5,542 | US$4.19M | 4.6% |
| Mettler-toledo International, Inc. | 2,865 | US$3.66M | 4.0% |
| Intuitive Surgical, Inc. | 8,960 | US$3.56M | 3.9% |
| Amgen Inc. | 9,757 | US$3.53M | 3.9% |
| The Cooper Companies, Inc. | 48,681 | US$3.49M | 3.8% |
| Idexx Laboratories, Inc. | 6,572 | US$3.46M | 3.8% |
| Thermo Fisher Scientific Inc | 6,684 | US$3.35M | 3.7% |
| Lumexa Imaging Holdings, Inc. | 293K | US$3.3M | 3.6% |
| Healthequity, Inc. | 35,255 | US$3.18M | 3.5% |
| Danaher Corporation | 16,221 | US$3.09M | 3.4% |
| Dexcom, Inc. | 41,497 | US$2.79M | 3.0% |
| Regeneron Pharmaceuticals, Inc. | 4,260 | US$2.66M | 2.9% |
| Align Technology, Inc. | 15,674 | US$2.64M | 2.9% |
| Steris Plc (ireland) | 10,114 | US$2.13M | 2.3% |
| U.s. Physical Therapy, Inc. | 30,695 | US$2.11M | 2.3% |
| Globus Medical, Inc. | 25,630 | US$2.03M | 2.2% |
| Medline Inc. | 43,666 | US$1.72M | 1.9% |
| Prestige Consumer Healthcare Inc. | 32,069 | US$1.52M | 1.7% |
| Insulet Corporation | 0 | US$0 | 0.00% |
Source
View original at SEC
Related